vs

Side-by-side financial comparison of Information Services Group Inc. (III) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $61.2M, roughly 1.2× Information Services Group Inc.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 5.9%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $4.3M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -2.4%).

EBSCO Information Services, headquartered in Ipswich, Massachusetts, is a division of EBSCO Industries Inc., a private company headquartered in Birmingham, Alabama. EBSCO provides products and services to libraries of many types around the world. Its products include EBSCONET, a complete e-resource management system, and EBSCOhost, which supplies a fee-based online research service with 375 full-text databases, a collection of 600,000-plus ebooks, subject indexes, point-of-care medical refere...

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

III vs PBYI — Head-to-Head

Bigger by revenue
PBYI
PBYI
1.2× larger
PBYI
$75.5M
$61.2M
III
Growing faster (revenue YoY)
PBYI
PBYI
+21.8% gap
PBYI
27.7%
5.9%
III
More free cash flow
PBYI
PBYI
$10.1M more FCF
PBYI
$14.4M
$4.3M
III
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
-2.4%
III

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
III
III
PBYI
PBYI
Revenue
$61.2M
$75.5M
Net Profit
$2.6M
Gross Margin
44.8%
69.3%
Operating Margin
8.4%
22.7%
Net Margin
4.3%
Revenue YoY
5.9%
27.7%
Net Profit YoY
-14.1%
EPS (diluted)
$0.06
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
III
III
PBYI
PBYI
Q4 25
$61.2M
$75.5M
Q3 25
$62.4M
$54.5M
Q2 25
$61.6M
$52.4M
Q1 25
$59.6M
$46.0M
Q4 24
$57.8M
$59.1M
Q3 24
$61.3M
$80.5M
Q2 24
$64.3M
$47.1M
Q1 24
$64.3M
$43.8M
Net Profit
III
III
PBYI
PBYI
Q4 25
$2.6M
Q3 25
$3.1M
$8.8M
Q2 25
$2.2M
$5.9M
Q1 25
$1.5M
$3.0M
Q4 24
$3.0M
Q3 24
$1.1M
$20.3M
Q2 24
$2.0M
$-4.5M
Q1 24
$-3.4M
$-4.8M
Gross Margin
III
III
PBYI
PBYI
Q4 25
44.8%
69.3%
Q3 25
42.2%
77.7%
Q2 25
42.2%
76.5%
Q1 25
43.1%
77.1%
Q4 24
41.5%
76.4%
Q3 24
40.4%
63.9%
Q2 24
39.5%
77.4%
Q1 24
36.1%
75.5%
Operating Margin
III
III
PBYI
PBYI
Q4 25
8.4%
22.7%
Q3 25
7.4%
17.6%
Q2 25
7.6%
12.7%
Q1 25
5.7%
8.7%
Q4 24
0.3%
22.6%
Q3 24
7.0%
27.4%
Q2 24
5.7%
-4.6%
Q1 24
-3.7%
-5.3%
Net Margin
III
III
PBYI
PBYI
Q4 25
4.3%
Q3 25
4.9%
16.2%
Q2 25
3.5%
11.2%
Q1 25
2.5%
6.5%
Q4 24
5.3%
Q3 24
1.9%
25.2%
Q2 24
3.2%
-9.6%
Q1 24
-5.3%
-11.0%
EPS (diluted)
III
III
PBYI
PBYI
Q4 25
$0.06
$0.26
Q3 25
$0.06
$0.17
Q2 25
$0.04
$0.12
Q1 25
$0.03
$0.06
Q4 24
$0.07
$0.40
Q3 24
$0.02
$0.41
Q2 24
$0.04
$-0.09
Q1 24
$-0.07
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
III
III
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$28.7M
$97.5M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$94.7M
$130.3M
Total Assets
$211.0M
$216.3M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
III
III
PBYI
PBYI
Q4 25
$28.7M
$97.5M
Q3 25
$28.7M
$94.4M
Q2 25
$25.2M
$96.0M
Q1 25
$20.1M
$93.2M
Q4 24
$23.1M
$101.0M
Q3 24
$9.7M
$96.7M
Q2 24
$11.8M
$96.8M
Q1 24
$14.0M
$107.2M
Total Debt
III
III
PBYI
PBYI
Q4 25
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
III
III
PBYI
PBYI
Q4 25
$94.7M
$130.3M
Q3 25
$94.7M
$115.3M
Q2 25
$94.1M
$104.7M
Q1 25
$95.0M
$97.1M
Q4 24
$96.3M
$92.1M
Q3 24
$96.6M
$71.1M
Q2 24
$95.5M
$48.5M
Q1 24
$95.6M
$51.0M
Total Assets
III
III
PBYI
PBYI
Q4 25
$211.0M
$216.3M
Q3 25
$213.3M
$202.9M
Q2 25
$200.7M
$194.9M
Q1 25
$202.4M
$196.2M
Q4 24
$204.5M
$213.3M
Q3 24
$227.1M
$220.7M
Q2 24
$235.3M
$205.0M
Q1 24
$234.2M
$214.1M
Debt / Equity
III
III
PBYI
PBYI
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
III
III
PBYI
PBYI
Operating Cash FlowLast quarter
$5.1M
$14.4M
Free Cash FlowOCF − Capex
$4.3M
$14.4M
FCF MarginFCF / Revenue
7.0%
19.1%
Capex IntensityCapex / Revenue
1.2%
0.0%
Cash ConversionOCF / Net Profit
1.94×
TTM Free Cash FlowTrailing 4 quarters
$25.0M
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
III
III
PBYI
PBYI
Q4 25
$5.1M
$14.4M
Q3 25
$11.1M
$9.7M
Q2 25
$11.9M
$14.1M
Q1 25
$978.0K
$3.6M
Q4 24
$6.6M
$15.6M
Q3 24
$8.8M
$11.0M
Q2 24
$2.2M
$1.0M
Q1 24
$2.3M
$11.2M
Free Cash Flow
III
III
PBYI
PBYI
Q4 25
$4.3M
$14.4M
Q3 25
$9.5M
$9.7M
Q2 25
$11.1M
$14.1M
Q1 25
$141.0K
$3.6M
Q4 24
$6.0M
$15.6M
Q3 24
$8.4M
$11.0M
Q2 24
$1.3M
$1.0M
Q1 24
$1.3M
FCF Margin
III
III
PBYI
PBYI
Q4 25
7.0%
19.1%
Q3 25
15.2%
17.7%
Q2 25
18.0%
26.8%
Q1 25
0.2%
7.7%
Q4 24
10.4%
26.4%
Q3 24
13.7%
13.7%
Q2 24
2.0%
2.1%
Q1 24
2.0%
Capex Intensity
III
III
PBYI
PBYI
Q4 25
1.2%
0.0%
Q3 25
2.5%
0.0%
Q2 25
1.4%
0.0%
Q1 25
1.4%
0.1%
Q4 24
0.9%
0.0%
Q3 24
0.6%
0.0%
Q2 24
1.4%
0.0%
Q1 24
1.6%
0.0%
Cash Conversion
III
III
PBYI
PBYI
Q4 25
1.94×
Q3 25
3.62×
1.10×
Q2 25
5.46×
2.41×
Q1 25
0.66×
1.21×
Q4 24
2.15×
Q3 24
7.66×
0.54×
Q2 24
1.07×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons